Disrupted proportions of lymphocyte subsets were observed in CMV-IgM+ MDA5+ DM patients in the current study, including lower CD4+ T cells and CD19+ B cells in all MDA5+ patients (n = 89). This evidence concerns the gene CD4 and dermatomyositis.